{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T13:00:37Z","timestamp":1780923637638,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005672","name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Apoio \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011755","name":"National Center for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.drudis.2025.104535","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T10:10:13Z","timestamp":1763374213000},"page":"104535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease"],"prefix":"10.1016","volume":"30","author":[{"given":"J\u00falia Morales","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Ferreira Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danieli Fernanda","family":"Buccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9546-0525","authenticated-orcid":false,"given":"Octavio Luiz","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2025.104535_b0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","article-title":"Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management","volume":"161","author":"Rogler","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.drudis.2025.104535_b0010","article-title":"Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.drudis.2025.104535_b0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-023-01836-7","article-title":"Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report","volume":"73","author":"Cao","year":"2024","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drudis.2025.104535_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105075","article-title":"Inflammatory bowel disease-non-biological treatment","volume":"160","author":"Magro","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2025.104535_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655054","article-title":"An update for pharmacologists on new treatment options for inflammatory bowel disease: the clinicians\u2019 perspective","volume":"12","author":"Schmidt","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104535_b0030","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/biomedicines9121748","article-title":"Pharmacogenetics of biological agents used in inflammatory bowel disease: a systematic review","volume":"9","author":"Lauro","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104535_b0035","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.3390\/antibiotics11081062","article-title":"Synthetic antimicrobial immunomodulatory peptides: ongoing studies and clinical trials","volume":"11","author":"Lesiuk","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.drudis.2025.104535_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.668632","article-title":"Antimicrobial peptides: a new hope in biomedical and pharmaceutical fields","volume":"11","author":"Moretta","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.drudis.2025.104535_b0045","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.3390\/ijms222011172","article-title":"Host defense peptides: dual antimicrobial and immunomodulatory action","volume":"22","author":"Drayton","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104535_b0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s40104-022-00796-y","article-title":"The dual antimicrobial and immunomodulatory roles of host defense peptides and their applications in animal production","volume":"13","author":"Wu","year":"2022","journal-title":"J Anim Sci Biotechnol"},{"key":"10.1016\/j.drudis.2025.104535_b0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5483\/BMBRep.2016.49.9.098","article-title":"Promotion of formyl peptide receptor 1-mediated neutrophil chemotactic migration by antimicrobial peptides isolated from the centipede Scolopendra subspinipes mutilans","volume":"49","author":"Park","year":"2016","journal-title":"BMB Rep"},{"key":"10.1016\/j.drudis.2025.104535_b0060","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3389\/fimmu.2020.00983","article-title":"Strategies in translating the therapeutic potentials of host defense peptides","volume":"11","author":"Ting","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0065","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nchembio.1393","article-title":"Immune modulation by multifaceted cationic host defense (antimicrobial) peptides","volume":"9","author":"Hilchie","year":"2013","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.drudis.2025.104535_b0070","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.it.2014.07.004","article-title":"Host defense peptides: front-line immunomodulators","volume":"35","author":"Mansour","year":"2014","journal-title":"Trends Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12917-024-04202-9","article-title":"Discovery of Ll-CATH: a novel cathelicidin from the Chong\u2019an Moustache Toad (Leptobrachium liui) with antibacterial and immunomodulatory activity","volume":"20","author":"Chen","year":"2024","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.drudis.2025.104535_b0080","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1021\/acs.jafc.2c08522","article-title":"Host defense peptides in nutrition and diseases: a contributor of immunology modulation","volume":"71","author":"Dou","year":"2023","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.drudis.2025.104535_b0085","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1007\/s12010-024-04893-8","article-title":"Understanding the dynamics of human defensin antimicrobial peptides: pathogen resistance and commensal induction","volume":"196","author":"Kumaresan","year":"2024","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.drudis.2025.104535_b0090","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4014\/jmb.2301.01005","article-title":"Understanding the roles of host defense peptides in immune modulation: from antimicrobial action to potential as adjuvants","volume":"33","author":"Kim","year":"2023","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.drudis.2025.104535_b0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11274-023-03545-z","article-title":"Antibiofilm properties of cathelicidin LL-37: an in-depth review","volume":"39","author":"Memariani","year":"2023","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.drudis.2025.104535_b0100","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202216427","article-title":"Paneth cells as the cornerstones of intestinal and organismal health: a primer","volume":"15","author":"Wallaeys","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.drudis.2025.104535_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.900948","article-title":"Identification of crucial amino acid residues for antimicrobial activity of angiogenin 4 and its modulation of gut microbiota in mice","volume":"13","author":"Sultana","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2025.104535_b0110","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12958","article-title":"The roles and functions of Paneth cells in Crohn\u2019s disease: a critical review","volume":"54","author":"Yang","year":"2021","journal-title":"Cell Prolif"},{"key":"10.1016\/j.drudis.2025.104535_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1174140","article-title":"Paneth cell dysfunction in radiation injury and radio-mitigation by human \u03b1-defensin 5","volume":"14","author":"Shukla","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0120","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/cells10112991","article-title":"Human \u03b2-defensin 2 and its postulated role in modulation of the immune response","volume":"10","author":"Cie\u015blik","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.drudis.2025.104535_b0125","article-title":"Paneth cells as the origin of intestinal cancer in the context of inflammation","author":"Verhagen","year":"2023","journal-title":"Res Sq"},{"key":"10.1016\/j.drudis.2025.104535_b0130","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.3748\/wjg.v27.i43.7402","article-title":"Antimicrobial peptides and the gut microbiome in inflammatory bowel disease","volume":"27","author":"Gubatan","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.drudis.2025.104535_b0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00253-024-13400-2","article-title":"Effects of gut microbiota and metabolites on the host defense peptide expression","volume":"109","author":"Jin","year":"2025","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.drudis.2025.104535_b0140","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/antibiotics13070606","article-title":"A cyclic peptide based on pheasant cathelicidin inhibits influenza A H1N1 virus infection","volume":"13","author":"Pei","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.drudis.2025.104535_b0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/09506608.2022.2040293","article-title":"Critical material designs for mucus-and mucosa-penetrating oral insulin nanoparticle development","volume":"68","author":"Zaiki","year":"2023","journal-title":"Int Mater Rev"},{"key":"10.1016\/j.drudis.2025.104535_b0150","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3389\/fimmu.2020.00764","article-title":"Defensins: a double-edged sword in host immunity","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0155","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.3389\/fmicb.2020.01902","article-title":"Cathelicidin host defense peptides and inflammatory signaling: striking a balance","volume":"11","author":"Alford","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2025.104535_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129532","article-title":"Enhanced cell selectivity of hybrid peptides with potential antimicrobial activity and immunomodulatory effect","volume":"1864","author":"Miao","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.drudis.2025.104535_b0165","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s42003-023-05254-7","article-title":"Molecular hybridization strategy for tuning bioactive peptide function","volume":"6","author":"Pedron","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.drudis.2025.104535_b0170","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3389\/fimmu.2019.01841","article-title":"Design and development of a novel peptide for treating intestinal inflammation","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0175","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.3390\/ijms20163974","article-title":"A novel peptide ameliorates LPS-induced intestinal inflammation and mucosal barrier damage via its antioxidant and antiendotoxin effects","volume":"20","author":"Zhang","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104535_b0180","doi-asserted-by":"crossref","first-page":"16049","DOI":"10.1096\/fj.201903263RRR","article-title":"A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide\u2010receptor interaction","volume":"34","author":"Wei","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.drudis.2025.104535_b0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s43440-020-00190-3","article-title":"Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases","volume":"73","author":"Fabisiak","year":"2021","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.drudis.2025.104535_b0190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41392-023-01553-x","article-title":"Mechanisms and regulation of defensins in host defense","volume":"8","author":"Fu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.drudis.2025.104535_b0195","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.febslet.2009.06.051","article-title":"Selective arginines are important for the antibacterial activity and host cell interaction of human \u03b1-defensin 5","volume":"583","author":"De leeuw","year":"2009","journal-title":"FEBS Lett"},{"key":"10.1016\/j.drudis.2025.104535_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12967-020-02272-5","article-title":"An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via inhibiting NF-kB pathway","volume":"18","author":"Zeng","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.drudis.2025.104535_b0205","doi-asserted-by":"crossref","first-page":"32911","DOI":"10.1074\/jbc.M006098200","article-title":"The structure of human \u03b2-defensin-2 shows evidence of higher order oligomerization","volume":"275","author":"Hoover","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.drudis.2025.104535_b0210","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fimmu.2020.00093","article-title":"Human \u03b2-defensin 2 mediated immune modulation as treatment for experimental colitis","volume":"11","author":"Koeninger","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2023.105111","article-title":"Molecular characterization and antimicrobial activity of cecropin family in Hermetia illucens","volume":"152","author":"Peng","year":"2024","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13205-021-02948-9","article-title":"Antimicrobial peptide CC34 attenuates intestinal inflammation via downregulation of the NF-\u03baB signaling pathway","volume":"11","author":"Dong","year":"2021","journal-title":"3 Biotech"},{"key":"10.1016\/j.drudis.2025.104535_b0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10989-023-10545-y","article-title":"Antimicrobial efficacy and prevalence of microcins: low molecular mass bacteriocins produced by Escherichia coli","volume":"29","author":"Mohammadzadeh","year":"2023","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.drudis.2025.104535_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111127","article-title":"Recombinant antimicrobial peptide microcin J25 alleviates DSS-induced colitis via regulating intestinal barrier function and modifying gut microbiota","volume":"139","author":"Shang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2025.104535_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.811381","article-title":"A novel polymeric nanohybrid antimicrobial engineered by antimicrobial peptide MccJ25 and chitosan nanoparticles exerts strong antibacterial and anti-inflammatory activities","volume":"12","author":"Haitao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1102576","article-title":"The first Brevinin-1 antimicrobial peptide with LPS-neutralizing and anti-inflammatory activities in vitro and in vivo","volume":"14","author":"Tian","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.drudis.2025.104535_b0245","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/biomedicines12020345","article-title":"Chensinin-1b alleviates DSS-induced inflammatory bowel disease by inducing macrophage switching from the M1 to the M2 phenotype","volume":"12","author":"Sun","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2025.104535_b0250","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.3390\/ijms22157959","article-title":"Effects of lipidation on a proline-rich antibacterial peptide","volume":"22","author":"Armas","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2025.104535_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2024.171154","article-title":"The antimicrobial peptide Abaecin alleviates colitis in mice by regulating inflammatory signaling pathways and intestinal microbial composition","volume":"173","author":"Liu","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2025.104535_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.137171","article-title":"Adsorption characteristics of V-type starch for off-odors of sea cucumber intestinal peptides in solid-phase environment","volume":"433","author":"Shi","year":"2024","journal-title":"Food Chem"},{"key":"10.1016\/j.drudis.2025.104535_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122843","article-title":"Targeted V-type peptide-decorated nanoparticles prevent colitis by inhibiting endosomal TLR signaling and modulating intestinal macrophage polarization","volume":"314","author":"Li","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2025.104535_b0270","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2016.11.020","article-title":"Orally targeted delivery of tripeptide KPV via hyaluronic acid-functionalized nanoparticles efficiently alleviates ulcerative colitis","volume":"25","author":"Xiao","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.drudis.2025.104535_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270749","article-title":"Mechanisms of action of anti-inflammatory proteins and peptides with anti-TNF-alpha activity and their effects on the intestinal barrier: a systematic review","volume":"17","author":"Lima","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2025.104535_b0280","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3389\/fimmu.2020.01137","article-title":"Cathelicidins modulate TLR-activation and inflammation","volume":"11","author":"Scheenstra","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0285","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s44197-023-00145-w","article-title":"Evolving trends and burden of inflammatory bowel disease in Asia, 1990\u20132019: a comprehensive analysis based on the global burden of disease study","volume":"13","author":"Chen","year":"2023","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.drudis.2025.104535_b0290","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/intimm\/dxz060","article-title":"Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn\u2019s disease and regulate Th1\/Th17 cell responses","volume":"32","author":"Aguirre","year":"2020","journal-title":"Int Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0295","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/imm.13391","article-title":"Neutrophil\u2013T cell crosstalk in inflammatory bowel disease","volume":"164","author":"Kvedaraite","year":"2021","journal-title":"Immunology"},{"key":"10.1016\/j.drudis.2025.104535_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.622934","article-title":"Role of the IL23\/IL17 pathway in Crohn\u2019s disease","volume":"12","author":"Schmitt","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0305","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1038\/s41598-020-68993-1","article-title":"Monocytes from infliximab-resistant patients with Crohn\u2019s disease exhibit a disordered cytokine profile","volume":"10","author":"Gaiani","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2025.104535_b0310","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.drudis.2025.104535_b0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","article-title":"The nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases","volume":"8","author":"Zinatizadeh","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.drudis.2025.104535_b0320","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/glia.24181","article-title":"NFkB\u2010signaling promotes glial reactivity and suppresses M\u00fcller glia\u2010mediated neuron regeneration in the mammalian retina","volume":"70","author":"Palazzo","year":"2022","journal-title":"Glia"},{"key":"10.1016\/j.drudis.2025.104535_b0325","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/metabo13010096","article-title":"Phytochemicals and regulation of NF-kB in inflammatory bowel diseases: an overview of in vitro and in vivo effects","volume":"13","author":"Laurindo","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.drudis.2025.104535_b0330","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.3390\/metabo12111028","article-title":"Attenuation of palmitic acid-induced intestinal epithelial barrier dysfunction by 6-shogaol in caco-2 cells: the role of MiR-216a-5p\/TLR4\/NF-\u03baB axis","volume":"12","author":"Ouyang","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.drudis.2025.104535_b0335","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3389\/fimmu.2017.00843","article-title":"Thrombin-derived host-defense peptides modulate monocyte\/macrophage inflammatory responses to Gram-negative bacteria","volume":"8","author":"Hansen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2025.104535_b0340","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/acsptsci.4c00033","article-title":"Development of nontoxic peptides for lipopolysaccharide neutralization and sepsis treatment","volume":"7","author":"Fink","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.drudis.2025.104535_b0345","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semcdb.2018.02.002","article-title":"Modulation of toll-like receptor signaling by antimicrobial peptides","volume":"88","author":"Lee","year":"2019","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.drudis.2025.104535_b0350","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3390\/biom11070952","article-title":"Immunomodulatory properties of host defence peptides in skin wound healing","volume":"11","author":"Petkovic","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.drudis.2025.104535_b0355","article-title":"PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced colitis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2025.104535_b0360","doi-asserted-by":"crossref","first-page":"31254","DOI":"10.1021\/acsomega.4c02628","article-title":"Tips and tricks in the modeling of supramolecular peptide assemblies","volume":"9","author":"Piskorz","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.drudis.2025.104535_b0365","article-title":"Revolutionizing peptide\u2010based drug discovery: advances in the post\u2010AlphaFold era","volume":"14","author":"Chang","year":"2024","journal-title":"Wiley Interdiscip Rev: Comput Mol Sci"},{"key":"10.1016\/j.drudis.2025.104535_b0370","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10989-023-10524-3","article-title":"Strategic approaches to improvise peptide drugs as next generation therapeutics","volume":"29","author":"Barman","year":"2023","journal-title":"Int J Pept Res Ther"},{"key":"10.1016\/j.drudis.2025.104535_b0375","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/biof.1913","article-title":"Translational aspect in peptide drug discovery and development: an emerging therapeutic candidate","volume":"49","author":"Anand","year":"2023","journal-title":"Biofactors"},{"key":"10.1016\/j.drudis.2025.104535_b0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00005-021-00630-9","article-title":"Are host defense peptides and their derivatives ready to be part of the treatment of the next coronavirus pandemic?","volume":"69","author":"Rivas-santiago","year":"2021","journal-title":"Arch Immunol Ther Exp"},{"key":"10.1016\/j.drudis.2025.104535_b0385","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/asia.202100102","article-title":"Recent applications of aggregation induced emission probes for antimicrobial peptide studies","volume":"16","author":"Luu","year":"2021","journal-title":"Chem Asian J"},{"key":"10.1016\/j.drudis.2025.104535_b0390","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.MIB.0000172807.26748.16","article-title":"RDP58 is a novel and potentially effective oral therapy for ulcerative colitis","volume":"11","author":"Travis","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.drudis.2025.104535_b0395","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70212","article-title":"Anti\u2010inflammatory peptides as promising therapeutics agent against inflammatory bowel diseases: a systematic review","volume":"9","author":"Ghazvini","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.drudis.2025.104535_b0400","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/pharmaceutics13010064","article-title":"Chronic inflammatory diseases, anti-inflammatory agents and their delivery nanosystems","volume":"13","author":"Placha","year":"2021","journal-title":"Pharmaceutics"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462500248X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S135964462500248X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:06:36Z","timestamp":1780920396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S135964462500248X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S135964462500248X"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104535","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2025.104535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104535"}}